SPY329.20+2.54 0.78%
DIA265.96+0.48 0.18%
IXIC11,159.01+154.14 1.40%

Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Lowers Price Target to $609

Morgan Stanley maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Equal-Weight and lowers the price target from $611 to $609.

· 10/13/2020 10:16
Morgan Stanley maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Equal-Weight and lowers the price target from $611 to $609.